Clinical Trial Update: Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases [Phase 4]

View source ↗

Summary

Phase 4 trial update for PLACENTEX IM in patients with scleroderma, showing termination of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• PLACENTEX

Snippet

Sponsor: Mastelli S.r.l | Conditions: Scleroderma Disease | Phase 4 | Status: TERMINATED